{"name":"Swiss Pediatric Oncology Group","slug":"swiss-pediatric-oncology-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQaDgyRTZ3dWJPZnNHOEVUTV81UXNjVUZmNHFsVTBicnVaQmlCLWtib1BEWk90dU5fN1ZiRktkdTdtV0pfTGpDWHR0LUZITVBVME9fSzU5S3VJVm00RjUtLXNIamc3cFFQTGk0QVVoOElTSUhwSTRIOHZ1TXBHdmRMNmhBU29HSmJZYzRBNm9QeXYyQ05jblFUMDZmRlY4Wkd1T2dfLUVZaUVkNzJ2Z2hSYUo2ckhRYS1RTThjQXE2d0J2R0U?oc=5","date":"2026-03-09","type":"trial","source":"Reuters","summary":"Roche shares drop as oral breast cancer drug combination fails key trial - Reuters","headline":"Roche shares drop as oral breast cancer drug combination fails key trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQMk1DWWtmZEtSNzlYY0lQc1EzcnpzNW5mZEZkZUIzdU5HOFdaMG05WHllZWhyOG9lam1jZUxSTnJXRW5tR2lEVGUzVC04SDR4TmpLLTd6b2ctLUJtcXhfcWZDNWEtYS1Cb1NVZXloenZldFdIeFFwNFdZNXlBXzRVMjJrSmhET1gwN1RyVDNyLU5XQWQ3QUNQYmZuZ2g0SHI3UTktN0VFaXptMEJjelFKam9USTBCWjJxRkNCZnNFNGRaeV9La2RLVWdn?oc=5","date":"2026-03-02","type":"pipeline","source":"PBS","summary":"Novartis settles with Henrietta Lacks' estate over use of her cancer cells to advance medicine - PBS","headline":"Novartis settles with Henrietta Lacks' estate over use of her cancer cells to advance medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNQV9Ucmp5dE5ldHBKOS1UTl9fZ1htQmlGUWh4UnJSV2RxMEJpNnpMMHc2VEdWb2NMZ1hhYTJKSG9YTmdZRklRNHhtc1E4SjRZWXV0Q1dvd1F6TnBaUmJSeE9rNGg4c2VUeGhRWUhPWEtycEVYQ2NfQVN6Rm1Mcm16ZEN4dDVmSWJpZURwM0Y3SmRIWFVONDdSRVItSHZPR0E5bFAwRTZ3bkg1SXhtWTdXalln?oc=5","date":"2026-02-25","type":"pipeline","source":"Dallas Innovates","summary":"Global Pharma Giant Novartis To Build Next-Gen Cancer Drug Plant in Denton, Creating North Texas Jobs - Dallas Innovates","headline":"Global Pharma Giant Novartis To Build Next-Gen Cancer Drug Plant in Denton, Creating North Texas Jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQOVNLNUFSRXZBclVleGhmLW01NG5DQTlMZGJwYmN2azhTZEt4LUVQbC1sRXlyVHlDaERSTXU4S0s0c2ZiRERMM0cwX1pOdTVEazlsZlNiUDNjR0xXT3lWOEhyWlJOdUNXR21kUDVHcllQcVZOLTBDeWlHVEktd3hzeXBubzdJT004X01XSA?oc=5","date":"2026-01-12","type":"deal","source":"Yahoo Finance","summary":"Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology - Yahoo Finance","headline":"Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQdkRCWTJUMUVkMUxMVE5xbVdpYnIwN3FmdzRfZnExcldtNnlDS2V4Tmx1bERXdG1fellieW92b1djbHZ3ekg5RnBDc0xIVVVrY1pJeDFibmYzTDB2YUt3ZTREYmFMTzhFVERBTXJGZHZhaTlxbl9kSHdicVh3QkMtUlFvZ2Z5Mjh2a01fbmd3WVdpT2U1cnlWeXh5dkVIeFpVV1BkTlNkMkgyblpwOU5BRGZ4ak1RRWJtdEVSaWhVVjU1SGNkcHNwVUZUc0M?oc=5","date":"2025-11-18","type":"pipeline","source":"Reuters","summary":"Roche oral drug shown to keep breast cancer at bay, boosting shares - Reuters","headline":"Roche oral drug shown to keep breast cancer at bay, boosting shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQcDIwV0pOQUVLaDdWTG9FdS1TYzlzQmpsZ2FRY2I2aUdhdWdyUW1ZRHRDUXNqQkdKTXlDNGlkMVpEeWFSSmVfc2hZaWk0WlM0QkFSclhJd2NJb3RobVhZanpJV211OWs1RjNVVW9VdE5LVDFXOVVUSlZETGtvUGpJNmQxa0I?oc=5","date":"2025-09-10","type":"pipeline","source":"Pharma Voice","summary":"Pharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city. - Pharma Voice","headline":"Pharma’s new boomtown? Why drugmakers are setting up shop in a small Swiss city.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNQzZLTkJqZkNDX0hYMHZXTU9yOEtsbm9zUS05U2ZSemJQcU5nc05hT2dfTGhLLTFlR2I0bWl4TE5CVFhrRGVZem8wYXhGc0lNR2NWYlVZN2hkRk5iODFfcy1xUXNWM0pBZTRNYlBzLXdwMjhHTnQyNjc3WHlLZFJiLXJqb1o1ZWx6M2NkalVXOFotZDFja0c1N3hlc2htUnAwUFYxMVF0R3J6WXhUYmN1YkRQRmVpb3dMZU5mR21vODRhVkl0dlMyWVQ5cFJPRXVpdVhSanpoOVV5eVJpcHJvSS1LUDhmaDd0?oc=5","date":"2025-07-08","type":"regulatory","source":"PR Newswire","summary":"Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB) - PR Newswire","headline":"Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOaG9qODBpRmZpd2lpWlY2blE0azEzbHh2ay10WG9Za09BdXZJdzhGbXkxQjVBcm1wcHlIQmdBQktGNkVIZ3NrbE1FZVJPUnlabzk3MWdSRjVpVFo1c2Nhc0diZGFWQ3hwaFRBaFZibVV5cFU1aU1KWWM2SUEwZjQtbU5PTlV4aEtVdEJlSnpZMUF0bzRYeENxV1JtMzlxenBWZTBiaWlrTXU1eENULW5fVTBTNnRZamJkNkZCZUZXMlo?oc=5","date":"2025-05-28","type":"pipeline","source":"SWI swissinfo.ch","summary":"Biotech company BeiGene renames and relocates to Basel - SWI swissinfo.ch","headline":"Biotech company BeiGene renames and relocates to Basel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE1TeDhjQ18xWEZvZmZRUUozVi1jNnFFalA3ZUtjZUxQZEV6RTVaQWkwVGxTZFlWV3oxRVpkeU9JS0xYTEFITGpLczNMNA?oc=5","date":"2025-02-15","type":"pipeline","source":"Oncodaily","summary":"OncoThon 2025 - Oncodaily","headline":"OncoThon 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNZ3RweGRYLTlmWHBYS2ZGbkZVQ09xekRZei16RkZDa1dTSEp2dTFKNGtDZUlHa0ZUOGN2eWZ6UzNoclVXalZjcWRLMnF3WGJSZ1g3b1BHOTgtMHFFMXZTZWxqODRIaGNzT3A0QmdJQ0tZYjRiOVR4SkJwQUY4N1hRdENYMk9CWHZmd3hJZ3p3NzY3N1Ay?oc=5","date":"2024-05-31","type":"regulatory","source":"Frontiers","summary":"Reflections on the regulatory field covering the development of paediatric medicinal products: a brief overview of current status and challenges - Frontiers","headline":"Reflections on the regulatory field covering the development of paediatric medicinal products: a brief overview of curre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPWEpoNGo4Q0JBb1BndTlqZEZOUjZNZmZ3aWpSeERBUjdsdU1uYk8wdHZTeG5CQnY4QmNsUnRZQ2xDdTM1R2IzejlSMWYwNG04NXB1Sm5kZDBjMTZpRUNmcGlSa20yMUhSemZHUGp2ay1YT0pkbDR3a2s2ZzdtSmU2UGdtUQ?oc=5","date":"2023-02-08","type":"pipeline","source":"AbbVie","summary":"Little patients, big impact: Our approach to pediatric oncology - AbbVie","headline":"Little patients, big impact: Our approach to pediatric oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNc1EwNnJOc25rX01nUHhSWm51R2NUc3JuQWJyX0VzXzQta3B4a29TZ1BVU3czY0I0aEN2OUNNSlVxYUZ0b2d6NkZiaXd4bjlFVHRFSTh4a0lxTlFua3h1UEVuNEVRdTFjV3lOQW5ZbGtLaEFhaE10YTN3UnhhVVNlRE9pQ0VYSG0tTlZyZE1hUnBjM29JOWs5eVp0aUpGSEk?oc=5","date":"2022-06-06","type":"trial","source":"The University of Manchester","summary":"Study identifies best treatment for rare childhood cancer - The University of Manchester","headline":"Study identifies best treatment for rare childhood cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}